Intensity-modulated radiation therapy, protons, and the risk of second cancers.
By E. Hall. International Journal of Radiation Oncology, Biology, Physics, 2006
1,141 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Radiation, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/fb322a6de22065162b37b2d19c00cf6a938a1ab6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
- Á. González-Fernández
- Berta Sáez-Gutiérrez
- M. Valladares
- Marco Durante
- J. Lambea
- M. Arruebo
- A. Trés
- N. Vilaboa
In Radiation
- Á. González-Fernández
- Berta Sáez-Gutiérrez
- M. Valladares
- Marco Durante
- J. Lambea
- M. Arruebo
- A. Trés
- N. Vilaboa
In Radiology, Nuclear Medicine and Imaging
- Á. González-Fernández
- Berta Sáez-Gutiérrez
- M. Valladares
- Marco Durante
- J. Lambea
- M. Arruebo
- A. Trés
- N. Vilaboa
Citations in the corpus
- Particle radiation therapy using proton and heavier ion beams. (2007, neutral): “As long as modern delivery techniques are used, intensity-modulated actively delivered proton RT will always deliver less dose to normal nontarget tissue than photon intensity-modulated RT (IMRT) for most of the indications in pediatric radiation oncology.(33) The question is whether sparing of norm”
- Systemic effects of local radiotherapy (2009, neutral): “The nature of these signals and their role in radiation-induced second malignancies have been previously reviewed [2,15].”
- Assessment of the Evolution of Cancer Treatment Therapies (2011, methodology): “This treatment uses CT-guided IMRT technology that directs the radiation source by rotating it around the patient, which makes the morphological limits of a tumor easier to trace with the beam [31].”
- Charged particles in radiation oncology (2010, background): “Late effects and secondary cancers New radiation modalities have certainly improved local tumor control, but retain the potential to increase secondary cancers”
- Heavy-ion tumor therapy: Physical and radiobiological benefits (2010, neutral): “Hall, 2006; Hall and Brenner, 2006; Macklis, 2006; Paganetti et al., 2006; Xu et al., 2008".”
- Radiation-induced bystander signalling in cancer therapy (2009, neutral): “It is clearly of relevance to determine whether these changes in the delivery of radiation have consequences for patient outcome”